Amarantus Bioscience Holdings Inc (AMBS)

[68-Tele]

Other small cap biotechs give clear concise numbers pertaining to available funds on hand to carry through to a specific date, including clear current burn rate and projected future burn rate in 10Q and 10K.
They also give a clear listing of competition in 10K. An example would be one of Rubenfield's other Board associated companies which started working with ALS and then switched to a cancer focus. Upcoming AMBS 10Q will shed light on the truth of the matter.